Search
The Newsletter
The Principals
Reports
Conferences
Physician Surveys
Consulting
Contact Us
 
Home
 


Online Report Subscribers, Click Here


 Pricing and Ordering Information

European Markets for Arrhythmia Management Products
February 2001, 278 pages
Report #RP-481420

Heart disease is the world’s leading cause of death for both men and women among all racial and ethnic groups.  Each year, arrhythmia disease claims approximately 400,000 lives and costs up to $30 billion in combined healthcare spending in France, Germany, Italy, Spain, and the United Kingdom.  In 1999, cardiac rhythm management devices were used in more than 683,000 elective and emergency arrhythmia procedures on patients in these European countries.  As life expectancies in the Western European nations continue to rise, so do the chances of facing heart disease.

Estimations from the World Health Organization predict that by the year 2020, up to 40% of all deaths will be related to diseases of the heart.  By the year 2005, combined revenues from the sales of pacemakers, implantable cardioverter defibrillators, congestive heart failure-targeting cardiac stimulators, external defibrillation products and electrophysiology catheters are estimated to grow at a compound annual growth rate of 6.6%.

This report by Medtech Insight provides clients with an in-depth analysis of the technologies, products, current and forecast markets, competitors, and opportunities in this dynamic market.  Major topics include:  anti-arrhythmia drug therapy; cardiac pacemakers; congestive heart failure-targeting cardiac stimulators; cryoablation; echocardiography; electrophysiology studies; external defibrillators; holter monitor studies; implantable cardioverter defibrillators; leads & electrodes; microwave arrhythmia ablation; radiofrequency arrhythmia ablation; resting electrocardiography; tilt table testing; and trans-telephonic event recording.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

i.    European Healthcare Environment

ii.    European Arrhythmia Management Product Markets

iii.   European Pacemaker Market

iv.   European Market for CHF-Targeting Cardiac Stimulators

v.   European Implantable Cardioverter Defibrillator Product Market

vi.   External Defibrillators

vii.  Electrophysiology Catheters

 

1. EUROPEAN MARKET OVERVIEW

     1.1 European Healthcare Reforms

     1.2 Reimbursement Practices

     1.3 Impact of the European Union

          1.3.1 Medical Device Regulations

     1.4 Healthcare Profiles of Selected European Nations

          1.4.1 France

          1.4.2 Germany

          1.4.3 Italy

          1.4.4 Spain

          1.4.5 United Kingdom

 

2. CLINICAL OVERVIEW OF ARRHYTHMIA DISORDERS

     2.1 Functional Anatomy and Electrophysiology of the Heart

          2.1.1 Cardiac Conduction System

     2.2 Common Cardiac Arrhythmias

          2.2.1 Sinus Bradycardia

          2.2.2 Sick Sinus Syndrome

          2.2.3 Heart Block

                  2.2.3.1 Atrioventricular Block

                  2.2.3.2 Infranodal Atrioventricular Block

                  2.2.3.3 Intraventricular Block

                  2.2.3.4 Sinoatrial Block

          2.2.4 Supraventricular Tachycardia

                  2.2.4.1 Atrial Fibrillation

                  2.2.4.2 His Bundle Rhythms

          2.2.5 Ventricular Tachycardia

                  2.2.5.1 Ventricular Fibrillation

          2.2.6 Sudden Cardiac Death

 

3. CLINICAL MANAGEMENT OF ARRHYTHMIA DISORDERS

     3.1 Diagnosing Arrhythmias

          3.1.1 Resting Electrocardiography

          3.1.2 Holter Monitor Studies

          3.1.3 Trans-Telephonic Event Recording

          3.1.4 Signal-Averaging Electrocardiography

          3.1.5 Exercise Stress Testing

          3.1.6 Echocardiography

          3.1.7 Tilt-Table Testing

          3.1.8 Electrophysiology Studies

     3.2 Therapeutic Management of Arrhythmia Disorders

          3.2.1 Anti-Arrhythmic Drug Therapy

          3.2.2 Cardiac Pacemakers

                  3.2.2.1 Pacing Technology

                  3.2.2.2 Fixed-Rate and Demand Devices

                  3.2.2.3 Single- and Dual-Chamber Devices

                  3.2.2.4 Rate-Responsive Devices

                  3.2.2.5 Ventricular Resynchronization Therapy Systems

                  3.2.2.6 Leads and Electrodes

                  3.2.2.7 Pacemaker Selection and Programming

                  3.2.2.8 Temporary Pacing Systems

                  3.2.2.9 Pacemaker Implantation Procedure Volumes

          3.2.3 Implantable Cardioverter Defibrillators

                  3.2.3.1 Implantable Cardioverter Defibrillator Technology

                  3.2.3.2 International Implantable Cardioverter Defibrillator

                            System Codes

                  3.2.3.3 Implantable Cardioverter Defibrillator Product

                            Selection

                  3.2.3.4 Implantable Cardioverter Defibrillator Implantation

                            Procedure

                  3.2.3.5 Utilization of Implantable Cardioverter Defibrillators

                             in European Clinical Practices

          3.2.4 External Defibrillators

                  3.2.4.1 External Defibrillation Technology

                  3.2.4.2 Defibrillation Sites

          3.2.5 Surgical Treatment of Arrhythmia Disorders

          3.2.6 Arrhythmia Ablation

                  3.2.6.1 Indications for Conventional Radiofrequency

                             Ablation in Arrhythmia Management

                  3.2.6.2 Advanced Systems for Tachyarrhythmia

                             Radiofrequency Ablation

                  3.2.6.3 Microwave Arrhythmia Ablation

                  3.2.6.4 Cryoablation Techniques for Tachycardia

                             Management

                  3.2.6.5 Arrhythmia Ablation Procedure Volumes

 

4. EUROPEAN ARRHYTHMIA MANAGEMENT PRODUCTS MARKETS

     4.1 Pacemakers and Pacing-Based Cardiac Stimulators

          4.1.1 Pacemaker Market Forecast

          4.1.2 Competitive Analysis

     4.2 Congestive Heart Failure-Targeting Cardiac Stimulators

          4.2.1 Cardiac Stimulator Market Forecast

          4.2.2 Competitive Analysis

     4.3 Implantable Cardioverter Defibrillator Systems

          4.3.1 Market Forecast

          4.3.2 Competitive Analysis

     4.4 External Defibrillators

          4.4.1 Market Forecast

          4.4.2 Competitive Analysis

     4.5 Electrophysiology Catheter Marketplace

          4.5.1 Electrophysiology Diagnostic Catheters

                  4.5.1.1 Market Forecast

                  4.5.1.2 Competitive Analysis

          4.5.2 Radiofrequency Ablation Catheters

                  4.5.2.1 Market Forecast

                  4.5.2.2 Competitive Analysis

 

5. COMPANY PROFILES

5.1    AFx, Inc.

5.2    Agilent Technologies, Inc.

5.3    Arrow International, Inc.

5.4    C.R. Bard, Inc.

5.5    Biosense Webster/Johnson & Johnson

5.6    Biotronik GmbH & Co.

5.7    Boston Scientific Corporation

5.8    Cardiac Pathways Corporation

5.9    Cardima, Inc.

5.10   CryoCath Technolgies, Inc.

5.11   Ela Medical, LLC

5.12   Endocardial Solutions, Inc

5.13   GE Marquette Hellige/General Electric Company

5.14   Guidant Corporation

5.15   Medtronic, Inc.

5.16   St. Jude Medical, Inc.

5.17   VascoMed - Institut für Kathetertechnologie GmbH

5.18   Vygon SA

5.19   ZOLL Medical Corporation

 

COMPANY LISTING
 

LIST OF EXHIBITS

 

Exhibit ES-1:  1999, Europe, Selected Healthcare Statistics 

Exhibit ES-2:  Europe, Invasive Arrhythmia Management, Procedure Volumes Forecast, 1999-2005 

Exhibit ES-3:  Europe, Arrhythmia Management Products, Market Forecast, 1999-2005 

Exhibit ES-4:  Europe, Arrhythmia Management Devices, Market Forecast, 1999-2005 

Exhibit ES-5:  Europe, Pacemakers, Market Forecast, 1999-2005 

Exhibit ES-6:  Europe, Cardiac Stimulators for Congestive Heart Failure Indications, Market Forecast, 1999-2005 

Exhibit ES-7:  Europe, Implantable Cardioverter Defibrillators, Market Forecast, 1999-2005 

Exhibit ES-8:  Europe, External Defibrillator Products, Market Forecast, 1999-2005 

Exhibit ES-9:  Europe, Electrophysiology Catheters, Market Forecast, 1999-2005 

 

Exhibit 1-1:    1999, Europe, Selected Healthcare Statistics 

Exhibit 1-2:    1998, France, Selected Healthcare Statistics 

Exhibit 1-3:    1998, Germany, Selected Healthcare Statistics 

Exhibit 1-4:    1998, Italy, Selected Healthcare Statistics 

Exhibit 1-5:    1998, Spain, Selected Healthcare Statistics 

Exhibit 1-6:    1998, United Kingdom, Selected Healthcare Statistics 

 

Exhibit 3-1:    Europe, Diagnostic Electrophysiology, Procedure Volumes Forecast, 1999-2005 

Exhibit 3-2:    Major Cardiac Rhythm Disorders and Established Treatment Protocols 

Exhibit 3-3:    Vaughn Williams Classification of Anti-Arrhythmic Drugs, by Action Mechanism 

Exhibit 3-4:    Pacemaker Codes 

Exhibit 3-5:    Pacemaker Rate-Modulated Sensing Technologies 

Exhibit 3-6:    Comparison of Rate-Adaptive Pacing Methods 

Exhibit 3-7:    Rate-Adaptive Pacing Modalities for the Management of Atrial Tachyarrhythmias and Endless-Loop Tachycardias 

Exhibit 3-8:    Europe, Pacemaker Placement Forecast, 1999-2005 

Exhibit 3-9:    NASPE/BPEG Defibrillator Coding 

Exhibit 3-10:  Examples of NASPE/BPEG (NBD) Defibrillator Code Usage 

Exhibit 3-11:  Europe, Implantable Cardioverter Defibrillator Placement Forecast, 1999-2005 

Exhibit 3-12:  Europe, Arrhythmia Ablation, Procedure Volumes Forecast, by Country, 1999-2005 

 

Exhibit 4-1:    Europe, Invasive Arrhythmia Management, Procedure Volumes Forecast, 1999-2005 

Exhibit 4-2:    Europe, Arrhythmia Management Products, Market Forecast, 1999-2005 

Exhibit 4-3:    Europe, Arrhythmia Management Devices, Market Forecast, by Country, 1999-2005 

Exhibit 4-4:    2000, Europe, Selected Pacemaker Systems 

Exhibit 4-5:    2000, Europe, Selected Cardiac Stimulators for Congestive Heart Failure Indications 

Exhibit 4-6:    Europe, Pacemakers, Market Forecast, 1999-2005 

Exhibit 4-7:    France, Pacemakers, Market Forecast, 1999-2005 

Exhibit 4-8:    Germany, Pacemakers, Market Forecast, 1999-2005 

Exhibit 4-9:    Italy, Pacemakers, Market Forecast, 1999-2005 

Exhibit 4-10:  Spain, Pacemakers, Market Forecast, 1999-2005 

Exhibit 4-11:  United Kingdom, Pacemakers, Market Forecast, 1999-2005 

Exhibit 4-12:  1999, Europe, Pacemaker Market, Share by Supplier 

Exhibit 4-13:  Europe, Cardiac Stimulators for Congestive Heart Failure Indications, Market Forecast, 1999-2005 

Exhibit 4-14:  1999, Europe, Cardiac Stimulators for Congestive Heart Failure Therapy Devices Market, Share by Supplier 

Exhibit 4-15:  2000, Europe, Selected Implantable Cardioverter Defibrillator Products 

Exhibit 4-16:  Europe, Implantable Cardioverter Defibrillators, Market Forecast, by Country, 1999-2005 

Exhibit 4-17:  France, Implantable Cardioverter Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-18:  Germany, Implantable Cardioverter Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-19:  Italy, Implantable Cardioverter Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-20:  Spain, Implantable Cardioverter Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-21:  United Kingdom, Implantable Cardioverter Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-22:  1999, Europe, Implantable Cardioverter Defibrillators, Share by Supplier 

Exhibit 4-23:  2000, Europe, Selected External Defibrillator Products, by Company 

Exhibit 4-24:  Europe, External Defibrillator Products, Market Forecast, 1999-2005 

Exhibit 4-25:  France, External Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-26:  Germany, External Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-27:  Italy, External Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-28:  Spain, External Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-29:  United Kingdom, External Defibrillators, Market Forecast, 1999-2005 

Exhibit 4-30:  1999, Europe, External Defibrillator Products Market, Share by Supplier 

Exhibit 4-31:  Europe, Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-32:  2000, Europe, Selected Diagnostic Electrophysiology Catheter Products 

Exhibit 4-33:  Europe, Diagnostic Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-34:  France, Diagnostic Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-35:  Germany, Diagnostic Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-36:  Italy, Diagnostic Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-37:  Spain, Diagnostic Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-38:  United Kingdom, Diagnostic Electrophysiology Catheters, Market Forecast, 1999-2005 

Exhibit 4-39:  1999, Europe, Conventional Diagnostic Electrophysiology Catheters Market, Share by Supplier 

Exhibit 4-40:  1999, Europe, Advanced Diagnostic Electrophysiology Catheters Market, Share by Supplier 

Exhibit 4-41:  2000, Europe, Selected Radiofrequency Ablation Catheters 

Exhibit 4-42:  Europe, Radiofrequency Ablation Catheters, Market Forecast, 1999-2005 

Exhibit 4-43:  France, Radiofrequency Ablation Catheters, Market Forecast, 1999-2005 

Exhibit 4-44:  Germany, Radiofrequency Ablation Catheters, Market Forecast, 1999-2005 

Exhibit 4-45:  Italy, Radiofrequency Ablation Catheters, Market Forecast, 1999-2005 

Exhibit 4-46:  Spain, Radiofrequency Ablation Catheters, Market Forecast, 1999-2005 

Exhibit 4-47:  United Kingdom, Radiofrequency Ablation Catheters, Market Forecast, 1999-2005 

Exhibit 4-48:  1999, Europe, Conventional Radiofrequency Ablation Catheters Market, Share by Supplier 

Exhibit 4-49:  1999, Europe, Advanced Radiofrequency Ablation Catheters Market, Share by Supplier 

 

Copyright 2001, Medtech Insight, LLC


Ordering Information

Title

 Report# Publication
Date		 List Price

European Markets for Arrhythmia Management Products

RP-481420

 February
2001

$3,100*

 

*The pdf version of each report costs an additional $500 when purchased in addition to the hardcopy.

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.219.0150 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.219.0037.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home